Mira Pharmaceuticals (MIRA) Interest Expenses (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Interest Expenses of $396.0 for Q4 2025, down 96.82% sequentially from $12441.0 in Q3 2025, and up 101.04% YoY from $196.98 in Q4 2024.
Mira Pharmaceuticals (MIRA) Interest Expenses (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 4 years of Interest Expenses data on file, last reported at $396.0 in Q4 2025.
- Quarterly Interest Expenses rose 101.04% year-over-year to $396.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$8584.0 (up 93.2% YoY) and the FY2025 annual result came in at $13072.0, up 107.89% from the prior year.
- Interest Expenses declined to $396.0 in Q4 2025 per MIRA's latest filing, from $12441.0 in the prior quarter.
- The five-year high for Interest Expenses was $3.5 million in Q4 2023, with the low at -$50416.0 in Q1 2024.
- Average Interest Expenses over 4 years is $339274.8, with a median of $1709.5 recorded in 2022.
- Year-over-year, Interest Expenses surged 196774.8% in 2023 and tumbled 3149.97% in 2024.
- Mira Pharmaceuticals' Interest Expenses stood at $1766.0 in 2022, then surged by 196774.8% to $3.5 million in 2023, then sank by 101.1% to -$38105.0 in 2024, then soared by 101.04% to $396.0 in 2025.
- Business Quant data shows MIRA's Interest Expenses at $396.0 in Q4 2025, $12441.0 in Q3 2025, and -$21421.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 272.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -393.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 657.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 240.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -343.00 Mn |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - | 396.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 396.00 |
| Dec 31, 2025 | 396.00 |
| Sep 30, 2025 | 12,441.00 |
| Sep 30, 2025 | 12,441.00 |
| Mar 31, 2025 | -21,421.00 |
| Mar 31, 2025 | -21,421.00 |
| Dec 31, 2024 | -38,105.00 |
| Dec 31, 2024 | -38,105.00 |
| Sep 30, 2024 | -37,752.00 |
| Sep 30, 2024 | -37,752.00 |
| Mar 31, 2024 | -50,416.00 |
| Mar 31, 2024 | -50,416.00 |
| Dec 31, 2023 | 3.48 Mn |
| Dec 31, 2023 | 3.48 Mn |
| Sep 30, 2023 | 427,732.00 |
| Sep 30, 2023 | 427,732.00 |
| Jun 30, 2023 | 295,887.00 |
| Jun 30, 2023 | 295,887.00 |
| Mar 31, 2023 | 1,653.00 |
| Mar 31, 2023 | 1,653.00 |